Patient | Sex | Age (years) | 28-day mortality | Site of infection | SAPS 2/SOFA score (baseline) | Disease severity | Cultures positivea |
---|---|---|---|---|---|---|---|
1 | Male | 62 | Survivor | Pneumonia | 45/5 | Septic shock | Enterococcus aerogenes |
2 | Male | 43 | Nonsurvivor | Peritonitis | 44/11 | Septic shock | None |
3 | Male | 64 | Survivor | Necrotizing pancreatitis | 38/7 | Septic shock | Enterococcus cloacae |
4 | Male | 54 | Survivor | Peritonitis | 52/2 | Severe sepsis | Coagulase-negative Staphylococcus, Candida albicans |
5 | Male | 60 | Survivor | Mediastinitis | 22/5 | Severe sepsis | Pseudomonas aeruginosa, Enterococcus faecium |
6 | Male | 75 | Survivor | Pneumonia | 42/8 | Septic shock | Escherichia coli |
7 | Female | 59 | Survivor | Peritonitis | 33/4 | Severe sepsis | Enterococcus faecalis |
8 | Male | 64 | Nonsurvivor | Pneumonia | 30/4 | Septic shock | E. cloacae |
9 | Male | 46 | Survivor | Necrotizing pancreatitis | 29/11 | Septic shock | P. aeruginosa, E. faecalis, coagulase-negative Staphylococcus |
10 | Male | 66 | Survivor | Pneumonia | 29/7 | Septic shock | Klebsiella oxytoca |
11 | Female | 53 | Survivor | Pneumonia | 33/9 | Septic shock | Klebsiella pneumoniae |
12 | Male | 52 | Survivor | Peritonitis | 24/3 | Septic shock | E. coli, P. aeruginosa |
13 | Male | 54 | Survivor | Mediastinitis | 23/8 | Severe sepsis | E. faecalis |
14 | Male | 65 | Nonsurvivor | Pneumonia | 30/5 | Severe sepsis | E. aerogenes |
15 | Male | 79 | Survivor | Graft infection | 33/4 | Severe sepsis | Coagulase-negative Staphylococcus., E. faecium |
16 | Female | 51 | Survivor | Necrotizing pancreatitis | 29 5 | Septic shock | C. albicans, Staphylococcus aureus |